on behalf of the XaNADU-ACS Investigators. First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS Trial - Alexander, JH; Dyke, CK; Yang, H (J Thromb Haemost, 2005)
et al.